Long-Term Effects Of An Early Individualised Retraining Programme On Walking Ability In Patients Following Hemiplegic Stroke
NCT ID: NCT01907451
Last Updated: 2013-07-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
14 participants
OBSERVATIONAL
2010-05-31
2011-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Analysis of the Psychometric Properties of Kinematic Parameters of Locomotion Measured by Inertial Units. Validation in Healthy Volunteers and Stroke Patients
NCT05104645
Physiotherapy in Order to Improve Walking Capacity and Participation in Chronic Stroke Subjects
NCT02543450
Use of Inertial Sensors to Characterize the Fatigability of Post-stroke Hemiplegic Patients
NCT05793047
Efficacy of a Mechanical Gait Repetitive Training Technique in Hemiparetic Stroke Patients (AVC)
NCT00284115
Determinants of Balance Recovery After Stroke - Retrospective Study
NCT03203109
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
The control group
will receive support "traditional"10 hours per week: techniques called neuro-facilitators
No interventions assigned to this group
test group
enjoy the same support as control group at 7 hours week, coupled with a personalized retraining effort ergometer for 3 hours per week: after a 5 minute warm to 50% of Heart Rate Maximum (HRmax) of the initial test effort (TE), continuous work of 20 minutes at an intensity corresponding to 70% HRmax, followed by a recovery period of 5 min between active 40 and 50% of maximum heart rate (5 times per week).
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age between 18 and 85 years.
* Etiological examination carried out according to current recommendations (CT scan and/or MRI, Holter ECG and Holter blood pressure, Doppler of the supra-aortic trunks, echocardiography).
* Patients referred to the PMR unit less than one month after the cerebral vascular accident.
* Clinical status considered stable from a cardiovascular and neurological point of view with a well-balanced medical treatment (anti-hypertensives, anti-coagulants or antiplatelets, oral antidiabetics if necessary)
* Patients able to understand the instructions and the interest of retraining.
* Patients who have provided written informed consent for the study.
Exclusion Criteria
* Patients referred following meningeal hemorrhage or deep vein thrombosis
* Recurrent stroke, whatever the severity of the sequelae of the previous stroke.
* Existence of cerebellar involvement as a major aspect of the clinical picture
* Myocardial infarction or heart surgery within the preceding 6 months.
* Severe heart failure (NYHA \>3 or left ventricular ejection fraction (LVEF) \<40%).
* Subjects presenting with complete non-stabilized arrhythmia
* Any metabolic, infectious, inflammatory, respiratory or cardiovascular disease that is not stabilized or constitutes a contra indication to retraining (chronic respiratory insufficiency (obstructive or restrictive), severe valve disease, obstructive heart disease, severe progressive heart rhythm or conduction disorders, intracavitary thrombus.
* Symptomatic peripheralartery disease (Leriche and Fontaine stage 3 or 4).
* Any other debilitating neurological disease (multiple sclerosis, Parkinson's disease).
* Participation in another biomedical research protocol during the retraining period (8 weeks minimum)
* Patients under guardianship or ward of court.
18 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire Dijon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Casillas PHRC IR 2009
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.